| GPRC5D-targeted CAR T cells for myeloma S Mailankody, SM Devlin, J Landa, K Nath, C Diamonte, EJ Carstens, ... New England Journal of Medicine 387 (13), 1196-1206, 2022 | 165 | 2022 |
| Tunneling kinetics and nonadiabatic proton-coupled electron transfer in proteins: the effect of electric fields and anharmonic donor–acceptor interactions B Salna, A Benabbas, D Russo, PM Champion The Journal of Physical Chemistry B 121 (28), 6869-6881, 2017 | 29 | 2017 |
| Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer J Tsuji, T Li, A Grinshpun, T Coorens, D Russo, L Anderson, R Rees, ... Clinical Cancer Research 28 (23), 5066-5078, 2022 | 9 | 2022 |
| Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy VN Parikh, AG Ioannidis, D Jimenez-Morales, JE Gorzynski, HN De Jong, ... Nature Communications 13 (1), 5107, 2022 | 5 | 2022 |
| Abstract GS3-07: GS3-07 Clonal evolution and mechanisms of acquired resistance to CDK4/6 inhibitors in ER-wild type and ER-mutant breast cancer C Guarducci, S Cristea, A Feit, S Naumenko, A Nardone, W Ma, D Russo, ... Cancer Research 83 (5_Supplement), GS3-07-GS3-07, 2023 | 3 | 2023 |
| Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer F Hermida-Prado, Y Xie, S Sherman, Z Nagy, D Russo, T Akhshi, Z Chu, ... Cancer Research 83 (19), 3284-3304, 2023 | 2 | 2023 |
| Longitudinal circulating tumor DNA (ctDNA) whole-exome sequencing (WES) in the phase Ib/II trial of palbociclib and bazedoxifene reveals genomic dynamics and clonal evolution … A Grinshpun, J Tsuji, T Li, D Russo, L Anderson, R Rees, C Cibulskis, ... Journal of Clinical Oncology 40 (16_suppl), 1058-1058, 2022 | 2 | 2022 |
| Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor positive breast cancer C Guarducci, A Nardone, D Russo, Z Nagy, C Heraud, A Grinshpun, ... Clinical Cancer Research, 2024 | | 2024 |
| Selective CDK7 Inhibition Has Dual Activity in Treatment Resistant Estrogen Receptor Positive Breast Cancer C Guarducci, A Nardone, D Russo, Z Nagy, C Heraud, MJ Leventhal, ... | | |
